ArticleBMC research notes2011

Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial.

Andreas Maieron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.